Flow Cytometry-Based Measurable Residual Disease Assessment in Patients With Acute Myeloid Leukemia Receiving Non-Intensive Chemotherapy.
Options
BORIS DOI
Publisher DOI
PubMed ID
41856789
Date of Publication
2026-06
Publication Type
Article
Subject(s)
Language(s)
en
Contributor(s)
Haaksma, Lukas H | |
Reuvekamp, Tom | |
Croese, Kasper J | |
Muijtjens, Maximiliaan | |
Kelder, Angéle | |
den Hartog, Daphne | |
Scholten, Willemijn J | |
Klein, Saskia K | |
Stüssi, Georg | |
Griskevicius, Laimonas | |
Breems, Dimitri A | |
Tick, Lidwine | |
Herbers, Alexandra | |
de Jonge, Susan | |
Chitu, Dana A | |
Bachas, Costa | |
Huls, Gerwin | |
Cloos, Jacqueline | |
de Leeuw, David C |
Additional Credits
Series
American Journal of Hematology
Publisher
Wiley
ISSN
1096-8652
0361-8609
Access(Rights)
restricted